Strides Pharma Science informs about press release

06 Sep 2024 Evaluate
Strides Pharma Science has informed that it attached Press Release issued by the Company titled: ‘Strides receive USFDA approval for Theophylline Extended-Release Tablets, 300 mg and 450 mg’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

910.45 -27.95 (-2.98%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×